Holdings

Suzhou Frontline BioVentures Venture Capital Fund II L.P. (蘇州通和二期創業投資合夥企業(有限合夥))

As of Jul 1, 2025, Suzhou Frontline BioVentures Venture Capital Fund II L.P. (蘇州通和二期創業投資合夥企業(有限合夥)) reported 1 positions. Largest: Ocumension Therapeutics. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Ocumension Therapeutics62.4Mfirst reportJul 1, 2025